News
Martin Cannon, PhD | Meet a Scientist
Dr. Martin Cannon, of University of Arkansas for Medical Sciences (UAMS), is a 2021 recipient of OCRA’s Collaborative Research Development Grant. With his project, “Understanding and Targeting Myeloid Populations in Ovarian Cancer,” Dr. Cannon seeks to better understand the behavior of a type of immune cell that currently helps ovarian cancer tumors grow, in order … Continued
New Ways to Build Community and Broaden Your Support System this Summer
As the busy summer months approach, OCRA remains committed to expanding support and offering new opportunities for our community to engage with others impacted by ovarian or other gynecologic cancers. With that in mind, we are happy to launch the first Staying Connected: Summer Series. This new series of online support groups will focus on specific … Continued
Making a Difference in the Name of Mom
Mother’s Day signifies so much to so many—celebration, gratitude, and yes, remembrance or loss. This year, we want to acknowledge just some of our many supporters who have taken their love for their moms and transformed it into a gift for our entire community. Whether biking across the country or putting on a virtual play, … Continued
Benoît Bragantini, PhD | Meet a Scientist
Dr. Benoît Brangantini, of Mayo Clinic, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With his project, “Probing Homologous Recombination DNA Repair Factors in Chromatin by cryo-EM,” Dr. Bragantini aims to better understand how DNA damage and repair mechanisms can lead to ovarian cancer, and how these processes can be controlled to prevent ovarian … Continued
Springing into Action: Heroes Highlights
With spring finally upon us, we want to give a shout-out to a group of OCRA Heroes who welcomed the season by setting themselves into motion, both literally and figuratively, to raise awareness and funds for our shared cause. Movement was the main theme for all of these supporters, who helped keep the momentum going … Continued
Melanie Weigert, PhD | Meet a Scientist
Dr. Melanie Weigert, of University of Chicago, is a 2021 recipient of OCRA’s Mentored Investigator Grant. With her project, “Genome-Wide Profiling of 5-hydroxymethylcytosine on Cell-Free DNA,” Dr. Weigert aims to identify biomarkers that can predict how cancer cells will respond to platinum-based treatments, helping guide patients with potentially platinum-resistant cancer toward alternative therapies. Dr. Weigert’s … Continued
The Overview: February 2022
This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all of us at OCRA. Advocacy Patient Support & Programs Events Research Ways to Give
Our Community Needs YOU | Heroes Highlights
The ovarian cancer community is counting on a hero… and that OCRA Hero could be you! If you’re looking to do good in 2022, it can be as simple (and fun!) as turning your favorite activity into a fundraiser. You can increase awareness and support just by going cycling, getting crafty, giving a concert, gathering … Continued
The Overview | January 2022
Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community. Only three weeks into 2022, and we already have a lot to share. So, without further ado … Research … Continued
Even More Ways to Stay Connected and Get Support
OCRA is pleased to announce the offering of an additional four groups to our Staying Connected online support group series. Staying Connected is facilitated by our Patient Support team and meets weekly or monthly, depending on the focus of the group. The meetings provide connection with others who share similar experiences and concerns facing ovarian … Continued
Anne van Harten, PhD | Meet a Scientist
Dr. Anne van Harten, of the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award. With her project, “Targeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer,” Dr. van Harten is designing and testing a new compound to target a … Continued
